Science 10 June 1988: Vol. 240. no. 4858, pp. 1546 - 1548 DOI: 10.1126/science.3259727

Prev | Table of Contents | Next

Articles

The role of the receptor for advanced glycation end-products in lung fibrosis.

M. He, H. Kubo, K. Ishizawa, A. E. Hegab, Y. Yamamoto, H. Yamamoto, and M. Yamaya (2007)
Am J Physiol Lung Cell Mol Physiol 293, L1427-L1436
 |  Abstract »  |  Full Text »  |  PDF »

Self-vaccination by methamphetamine glycation products chemically links chronic drug abuse and cardiovascular disease.

J. Treweek, S. Wee, G. F. Koob, T. J. Dickerson, and K. D. Janda (2007)
PNAS 104, 11580-11584
 |  Abstract »  |  Full Text »  |  PDF »

Phosphorylation of Pleckstrin Increases Proinflammatory Cytokine Secretion by Mononuclear Phagocytes in Diabetes Mellitus.

Y. Ding, A. Kantarci, J. A. Badwey, H. Hasturk, A. Malabanan, and T. E. Van Dyke (2007)
J. Immunol. 179, 647-654
 |  Abstract »  |  Full Text »  |  PDF »

Vascular endothelial growth factor C promotes survival of retinal vascular endothelial cells via vascular endothelial growth factor receptor-2.

B. Zhao, G. Smith, J. Cai, A. Ma, and M. Boulton (2007)
Br. J. Ophthalmol. 91, 538-545
 |  Abstract »  |  Full Text »  |  PDF »

Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways.

A. Tedgui and Z. Mallat (2006)
Physiol Rev 86, 515-581
 |  Abstract »  |  Full Text »  |  PDF »

The Pathobiology of Diabetic Complications: A Unifying Mechanism.

M. Brownlee (2005)
Diabetes 54, 1615-1625
 |  Full Text »  |  PDF »

Advanced Glycation End Products Enhance Expression of Pro-apoptotic Genes and Stimulate Fibroblast Apoptosis through Cytoplasmic and Mitochondrial Pathways.

Z. Alikhani, M. Alikhani, C. M. Boyd, K. Nagao, P. C. Trackman, and D. T. Graves (2005)
J. Biol. Chem. 280, 12087-12095
 |  Abstract »  |  Full Text »  |  PDF »

Effects of Thalidomide on Intracellular Mycobacterium leprae in Normal and Activated Macrophages.

A. Tadesse and E. J. Shannon (2005)
Clin. Vaccine Immunol. 12, 130-134
 |  Abstract »  |  Full Text »  |  PDF »

Advanced glycation end products potentiate the stimulatory effect of glucose on macrophage lipoprotein lipase expression.

M.-C. Beauchamp, S.-E. Michaud, L. Li, M. R. Sartippour, and G. Renier (2004)
J. Lipid Res. 45, 1749-1757
 |  Abstract »  |  Full Text »  |  PDF »

Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes.

G. Basta, A. M. Schmidt, and R. De Caterina (2004)
Cardiovasc Res 63, 582-592
 |  Abstract »  |  Full Text »  |  PDF »

Glucose Metabolism and Coronary Heart Disease in Patients With Normal Glucose Tolerance.

F. C. Sasso, O. Carbonara, R. Nasti, B. Campana, R. Marfella, M. Torella, G. Nappi, R. Torella, and D. Cozzolino (2004)
JAMA 291, 1857-1863
 |  Abstract »  |  Full Text »  |  PDF »

Glucose Enhances Human Macrophage LOX-1 Expression: Role for LOX-1 in Glucose-Induced Macrophage Foam Cell Formation.

L. Li, T. Sawamura, and G. Renier (2004)
Circ. Res. 94, 892-901
 |  Abstract »  |  Full Text »  |  PDF »

Inflammation and Activated Innate Immunity in the Pathogenesis of Type 2 Diabetes.

J. C. Pickup (2004)
Diabetes Care 27, 813-823
 |  Abstract »  |  Full Text »  |  PDF »

Divergent Pathways of Gene Expression Are Activated by the RAGE Ligands S100b and AGE-BSA.

J. V. Valencia, M. Mone, J. Zhang, M. Weetall, F. P. Buxton, and T. E. Hughes (2004)
Diabetes 53, 743-751
 |  Abstract »  |  Full Text »  |  PDF »

Regulation of Cyclooxygenase-2 Expression in Monocytes by Ligation of the Receptor for Advanced Glycation End Products.

N. Shanmugam, Y. S. Kim, L. Lanting, and R. Natarajan (2003)
J. Biol. Chem. 278, 34834-34844
 |  Abstract »  |  Full Text »  |  PDF »

Relation Between Serum 3-Deoxyglucosone and Development of Diabetic Microangiopathy.

H. Kusunoki, S. Miyata, T. Ohara, B.-F. Liu, A. Uriuhara, H. Kojima, K. Suzuki, H. Miyazaki, Y. Yamashita, K. Inaba, et al. (2003)
Diabetes Care 26, 1889-1894
 |  Abstract »  |  Full Text »  |  PDF »

Infarct-induced chronic heart failure increases bidirectional protein movement across the alveolocapillary barrier.

C. G. De Pasquale, A. D. Bersten, I. R. Doyle, P. E. Aylward, and L. F. Arnolda (2003)
Am J Physiol Heart Circ Physiol 284, H2136-H2145
 |  Abstract »  |  Full Text »  |  PDF »

Expression and Function of Receptors for Advanced Glycation End Products in Bovine Corneal Endothelial Cells.

Y. Kaji, S. Amano, T. Usui, T. Oshika, K. Yamashiro, S. Ishida, K. Suzuki, S. Tanaka, A. P. Adamis, R. Nagai, et al. (2003)
Invest. Ophthalmol. Vis. Sci. 44, 521-528
 |  Abstract »  |  Full Text »  |  PDF »

Optimizing renal replacement therapy--a case for online filtration therapies?.

C. H. Beerenhout, J. P. Kooman, A. J. Luik, S. G. J. Jeuken-Mertens, F. M. van der Sande, and K. M. L. Leunissen (2002)
Nephrol. Dial. Transplant. 17, 2065-2070
 |  Full Text »  |  PDF »

A previously undescribed chemical link between smoking and metabolic disease.

T. J. Dickerson and K. D. Janda (2002)
PNAS 99, 15084-15088
 |  Abstract »  |  Full Text »  |  PDF »

Elevated C-Reactive Protein Associates With Early-Stage Carotid Atherosclerosis in Young Subjects With Type 1 Diabetes.

R. Hayaishi-Okano, Y. Yamasaki, N. Katakami, K. Ohtoshi, S.-I. Gorogawa, A. Kuroda, M. Matsuhisa, K. Kosugi, N. Nishikawa, Y. Kajimoto, et al. (2002)
Diabetes Care 25, 1432-1438
 |  Abstract »  |  Full Text »  |  PDF »

Covalent modification of proteins by cocaine.

S.-X. Deng, N. Bharat, M. C. Fischman, and D. W. Landry (2002)
PNAS 99, 3412-3416
 |  Abstract »  |  Full Text »  |  PDF »

What is diabetic renal disease?.

H. Gallagher and P. A Andrews (2002)
The British Journal of Diabetes & Vascular Disease 2, 96-100
 |  Abstract »  |  PDF »

Hemodialysis Membranes: Interleukins, Biocompatibility, and Middle Molecules.

W. H. Horl (2002)
J. Am. Soc. Nephrol. 13, S62-71
 |  Abstract »  |  Full Text »  |  PDF »

Dual roles for HMGB1: DNA binding and cytokine.

C. J. Czura, Haichao Wang, and K. J. Tracey (2001)
Innate Immunity 7, 315-321
 |  Abstract »  |  PDF »

Abnormal glucose tolerance, not small vessel diameter, is a determinant of long-term prognosis in patients treated with balloon coronary angioplasty.

Y Otsuka, S Miyazaki, H Okumura, S Yasuda, S Daikoku, I Morii, Y Sutani, Y Goto, and H Nonogi (2000)
Eur. Heart J. 21, 1790-1796
 |  Abstract »  |  PDF »

Local application of advanced glycation end products and intimal hyperplasia in the rabbit collared carotid artery.

H. M Crauwels, A. G Herman, and H. Bult (2000)
Cardiovasc Res 47, 173-182
 |  Abstract »  |  Full Text »  |  PDF »

The Importance of Hyperglycemia in the Nonfasting State to the Development of Cardiovascular Disease.

S. M. Haffner (1998)
Endocr. Rev. 19, 583-592
 |  Abstract »  |  Full Text »

Molecular cloning of genes differentially regulated by TNF-{alpha} in bovine aortic endothelial cells, fibroblasts and smooth muscle cells.

J. Lin, B. Liliensiek, M. Kanitz, U. Schimanski, H. Bohrer, R. Waldherr, E. Martin, G. Kauffmann, R. Ziegler, and P. P. Nawroth (1998)
Cardiovasc Res 38, 802-813
 |  Abstract »  |  Full Text »  |  PDF »

Clusters of Perifollicular Macrophages in Normal Murine Skin: Physiological Degeneration of Selected Hair Follicles by Programmed Organ Deletion.

S. Eichmüller, C. van der Veen, I. Moll, B. Hermes, U. Hofmann, S. Müller-Röver, and R. Paus (1998)
J. Histochem. Cytochem. 46, 361-370
 |  Abstract »  |  Full Text »

AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept.

A. Bierhaus, M. A Hofmann, R. Ziegler, and P. P Nawroth (1998)
Cardiovasc Res 37, 586-600
 |  Abstract »  |  Full Text »  |  PDF »

Abnormalities of Apolipoprotein E in the Acquired Immunodeficiency Syndrome.

C. Grunfeld, W. Doerrler, M. Pang, P. Jensen, K. H. Weisgraber, and K. R. Feingold (1997)
J. Clin. Endocrinol. Metab. 82, 3734-3740
 |  Abstract »  |  Full Text »  |  PDF »

Effect of Advanced Glycation End Product–Modified Albumin on Tissue Factor Expression by Monocytes : Role of Oxidant Stress and Protein Tyrosine Kinase Activation.

F. Khechai, V. Ollivier, F. Bridey, M. Amar, J. Hakim, and D. de Prost (1997)
Arterioscler. Thromb. Vasc. Biol. 17, 2885-2890
 |  Abstract »  |  Full Text »

Advanced Glycation End Product (AGE)–Mediated Induction of Tissue Factor in Cultured Endothelial Cells Is Dependent on RAGE.

A. Bierhaus, T. Illmer, M. Kasper, T. Luther, P. Quehenberger, H. Tritschler, P. Wahl, R. Ziegler, M. Muller, and P. P. Nawroth (1997)
Circulation 96, 2262-2271
 |  Abstract »  |  Full Text »

Accumulation of Pyrraline-modified Albumin in Phagocytes due to Reduced Degradation by Lysosomal Enzymes.

S. Miyata, B.-F. Liu, H. Shoda, T. Ohara, H. Yamada, K. Suzuki, and M. Kasuga (1997)
J. Biol. Chem. 272, 4037-4042
 |  Abstract »  |  Full Text »  |  PDF »

Macrophages induce apoptosis in normal cells in vivo.

G Diez-Roux and R. Lang (1997)
Development 124, 3633-3638
 |  Abstract »  |  PDF »

Protein Cross-linking by the Maillard Reaction. ISOLATION, CHARACTERIZATION, AND IN VIVO DETECTION OF A LYSINE-LYSINE CROSS-LINK DERIVED FROM METHYLGLYOXAL.

R. H. Nagaraj, I. N. Shipanova, and F. M. Faust (1996)
J. Biol. Chem. 271, 19338-19345
 |  Abstract »  |  Full Text »  |  PDF »

Cerebroprotective Effects of Aminoguanidine in a Rodent Model of Stroke.

K. M. Cockroft, M. Meistrell III, G. A. Zimmerman, D. Risucci, O. Bloom, A. Cerami, K. J. Tracey, and G. Feuerstein (1996)
Stroke 27, 1393-1398
 |  Abstract »  |  Full Text »

Wall Thickening of Common Carotid Arteries in Patients Affected by Noninsulin-Dependent Diabetes Mellitus: Relationship to Microvascular Complications.

A. Visona, L. Lusiani, A. Bonanome, G. Beltramello, L. Confortin, B. Papesso, F. Costa, and A. Pagnan (1995)
Angiology 46, 793-799
 |  Abstract »  |  PDF »

Matrix Nonenzymatic Glycosylation Leads to Altered Cellular Phenotype and Intracellular Tyrosine Phosphorylation.

G. Hasegawa, A. J. Hunter, and A. S. Charonis (1995)
J. Biol. Chem. 270, 3278-3283
 |  Abstract »  |  Full Text »  |  PDF »

Hemoglobin-AGE: a circulating marker of advanced glycosylation.

Z Makita, H Vlassara, E Rayfield, K Cartwright, E Friedman, R Rodby, A Cerami, and R Bucala (1992)
Science 258, 651-653
 |  Abstract »  |  PDF »

Targets for dioxin: genes for plasminogen activator inhibitor-2 and interleukin-1 beta.

T. Sutter, K Guzman, K. Dold, and W. Greenlee (1991)
Science 254, 415-418
 |  Abstract »  |  PDF »

CD36, a Member of the Class B Scavenger Receptor Family, as a Receptor for Advanced Glycation End Products.

N. Ohgami, R. Nagai, M. Ikemoto, H. Arai, A. Kuniyasu, S. Horiuchi, and H. Nakayama (2001)
J. Biol. Chem. 276, 3195-3202
 |  Abstract »  |  Full Text »  |  PDF »

Early Glycation Products Produce Pentosidine Cross-links on Native Proteins. NOVEL MECHANISM OF PENTOSIDINE FORMATION AND PROPAGATION OF GLYCATION.

P. Chellan and R. H. Nagaraj (2001)
J. Biol. Chem. 276, 3895-3903
 |  Abstract »  |  Full Text »  |  PDF »

Scavenger Receptor Class B Type I-mediated Reverse Cholesterol Transport Is Inhibited by Advanced Glycation End Products.

N. Ohgami, R. Nagai, A. Miyazaki, M. Ikemoto, H. Arai, S. Horiuchi, and H. Nakayama (2001)
J. Biol. Chem. 276, 13348-13355
 |  Abstract »  |  Full Text »  |  PDF »

To Advertise   |   Find Products